ondansetron has been researched along with Adenocarcinoma, Basal Cell in 5 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study is to examine the risk of uncontrolled chemotherapy-induced nausea/vomiting (CINV) among lung cancer patients receiving multi-day chemotherapy and ondansetron- or palonosetron-initiated prophylactic antiemetic regimens in a community oncology setting." | 7.78 | Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy. ( Balu, S; Buchner, D; Feinberg, B; Gilmore, J; Haislip, S; Jackson, J; Jain, G, 2012) |
| "The purpose of this study is to examine the risk of uncontrolled chemotherapy-induced nausea/vomiting (CINV) among lung cancer patients receiving multi-day chemotherapy and ondansetron- or palonosetron-initiated prophylactic antiemetic regimens in a community oncology setting." | 3.78 | Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy. ( Balu, S; Buchner, D; Feinberg, B; Gilmore, J; Haislip, S; Jackson, J; Jain, G, 2012) |
| "Heptaplatin is a newly developed platinum derivative which has been reported to be less toxic than cisplatin." | 2.70 | Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer. ( Ahn, JH; Bahng, H; Chang, HM; Kang, WC; Kang, YK; Kim, TW; Kim, WK; Lee, JS; Park, JS, 2002) |
| "Progressive encephalopathy and partial loss of vision were the main observed signs." | 2.39 | Subacute encephalopathic toxicity of cisplatin. ( Conrad, CA; Hong, WK; Verschraegen, C, 1995) |
| "Survival of patients with advanced gastric cancer with Krukenberg's tumor is poor." | 1.32 | [A case of type 4 gastric cancer, diagnosed after operation for Krukenberg's tumor, treated by TS-1 plus low-dose cisplatinum]. ( Akiba, Y; Aoki, D; Hibi, T; Ishii, H; Kato, S; Mukai, M; Naito, K; Takada, Y; Watanabe, C, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortés-Flores, AO | 1 |
| Jiménez-Tornero, J | 1 |
| Morgan-Villela, G | 1 |
| Delgado-Gómez, M | 1 |
| Zuloaga-Fernández Del Valle, CJ | 1 |
| García-Rentería, J | 1 |
| Rendón-Félix, J | 1 |
| Fuentes-Orozco, C | 1 |
| Macías-Amezcua, MD | 1 |
| Ambriz-González, G | 1 |
| Alvarez-Villaseñor, AS | 1 |
| Urias-Valdez, D | 1 |
| Chavez-Tostado, M | 1 |
| Contreras-Hernández, GI | 1 |
| González-Ojeda, A | 1 |
| Feinberg, B | 1 |
| Gilmore, J | 1 |
| Haislip, S | 1 |
| Jackson, J | 1 |
| Jain, G | 1 |
| Balu, S | 1 |
| Buchner, D | 1 |
| Ahn, JH | 1 |
| Kang, YK | 1 |
| Kim, TW | 1 |
| Bahng, H | 1 |
| Chang, HM | 1 |
| Kang, WC | 1 |
| Kim, WK | 1 |
| Lee, JS | 1 |
| Park, JS | 1 |
| Akiba, Y | 1 |
| Watanabe, C | 1 |
| Takada, Y | 1 |
| Naito, K | 1 |
| Aoki, D | 1 |
| Mukai, M | 1 |
| Kato, S | 1 |
| Hibi, T | 1 |
| Ishii, H | 1 |
| Verschraegen, C | 1 |
| Conrad, CA | 1 |
| Hong, WK | 1 |
1 review available for ondansetron and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Subacute encephalopathic toxicity of cisplatin.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blindness; Brain Diseases; Ci | 1995 |
2 trials available for ondansetron and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Effects of preoperative dexamethasone on postoperative pain, nausea, vomiting and respiratory function in women undergoing conservative breast surgery for cancer: Results of a controlled clinical trial.
Topics: Adenocarcinoma; Adult; Aged; Analgesics, Opioid; Antiemetics; Breast Neoplasms; Dexamethasone; Doubl | 2018 |
Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protoc | 2002 |
2 other studies available for ondansetron and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Prot | 2012 |
[A case of type 4 gastric cancer, diagnosed after operation for Krukenberg's tumor, treated by TS-1 plus low-dose cisplatinum].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; | 2003 |